Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-27

Clinical Trial Update: Treatment of Copper Intra Uterine Device Associated Heavy Menstrual Blood Loss [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating a treatment for heavy menstrual blood loss associated with copper intrauterine devices in menorrhagia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Copper intrauterine device (copper-containing intrauterine device)

Snippet

Sponsor: Assiut University | Conditions: Menorrhagia | Phase 3 | Status: UNKNOWN